Literature DB >> 28604754

RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.

T Sakurai, K Isogaya, S Sakai, M Morikawa, Y Morishita, S Ehata, K Miyazono, D Koinuma.   

Abstract

This corrects the article DOI: 10.1038/onc.2016.35.

Entities:  

Year:  2017        PMID: 28604754      PMCID: PMC5582209          DOI: 10.1038/onc.2017.191

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


Correction to: Oncogene (2016) 35, 5000–5009; doi:10.1038/onc.2016.35; published online 29 February 2016 Since the online publication of this article the authors found that one of the siRNAs used in Figure 2f was not specific for TTF-1/Nkx2.1. The authors thus wish to replace the figure with the new figure using siRNAs specific for TTF-1/Nkx2.1. The authors apologize for any inconvenience caused, and confirm that the conclusions drawn from this research are not affected by this correction.
Figure 2

(f) H441 cells were transfected with human RBM47 promoter-reporter construct in combination with control or TTF-1 siRNAs (siTTF-1#1 (HSS144278), siTTF-1#3 (HSS144277) and siTTF-1#4 (HSS144279; Thermo Fisher Scientific)). At 48 h after transfection, cells were collected and assayed for luciferase activities. siCT: control siRNA. Averages and standard deviations of the two independent experiments were shown for each condition. The Tukey−Kramer test of the R program (http://www.r-project.org/) was used for multiple comparisons of the data. F-test was performed for the equality of variances.

(f) H441 cells were transfected with human RBM47 promoter-reporter construct in combination with control or TTF-1 siRNAs (siTTF-1#1 (HSS144278), siTTF-1#3 (HSS144277) and siTTF-1#4 (HSS144279; Thermo Fisher Scientific)). At 48 h after transfection, cells were collected and assayed for luciferase activities. siCT: control siRNA. Averages and standard deviations of the two independent experiments were shown for each condition. The Tukey−Kramer test of the R program (http://www.r-project.org/) was used for multiple comparisons of the data. F-test was performed for the equality of variances.
  4 in total

Review 1.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

2.  A cell-to-patient machine learning transfer approach uncovers novel basal-like breast cancer prognostic markers amongst alternative splice variants.

Authors:  Jean-Philippe Villemin; Claudio Lorenzi; Marie-Sarah Cabrillac; Andrew Oldfield; William Ritchie; Reini F Luco
Journal:  BMC Biol       Date:  2021-04-12       Impact factor: 7.431

3.  Overexpression of TC2N is associated with poor prognosis in gastric cancer.

Authors:  Jianbo Xu; Xinde Ou; Jin Li; Qinbo Cai; Kaiyu Sun; Jingning Ye; Jianjun Peng
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

4.  Identification of survival-related alternative splicing signatures in acute myeloid leukemia.

Authors:  Biyu Zhang; Lei Yang; Xin Wang; Denggang Fu
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.